The first Neogenomics trade was made in Q3 2018.
Since then Steven Cohen bought shares five more times and sold shares on six occasions. The investor completely sold their stake between Q2 2024 and Q3 2024.
Avg closing price
Price range
Sold -1.03 Million shares
Q3 2024
Avg closing price
$15.63
Price range
$13.40
-
$17.73
Sold 53.1% shares (-1.17 Million shares)
Q2 2024
Avg closing price
$14.18
Price range
$13.01
-
$15.77
New holding (+2.2 Million shares)
Q1 2024
Avg closing price
$15.44
Price range
$14.06
-
$16.79
Sold -448 Thousand shares
Q4 2023
Avg closing price
$16.36
Price range
$11.66
-
$20.73
Increased shares by 250.0% (+320 Thousand shares)
Q3 2023